Protevion™ Hydrogel
Chronic wounds (e.g., diabetic foot ulcers, venous leg ulcers), burns, post-surgical incisions
Pre-clinicalActive
Key Facts
Indication
Chronic wounds (e.g., diabetic foot ulcers, venous leg ulcers), burns, post-surgical incisions
Phase
Pre-clinical
Status
Active
Company
About Bioheal Therapeutics
Bioheal Therapeutics is a San Diego-based regenerative medicine company focused on addressing significant unmet needs in wound care. Its core technology is a patented, porcine amnion-hyaluronic acid hydrogel designed to be conformable, moisture-retentive, and non-adherent, aiming to simplify clinical workflows. The company is currently in the pre-commercial stage, seeking FDA clearance for its lead product, Protevion™ Hydrogel, which targets a large and growing market for advanced wound management. As a private, early-stage company, its near-term success hinges on regulatory approval and subsequent market adoption.
View full company profile